Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease
Clinical trial NCT01616680 · WITHDRAWN
Trial details
- NCT number
- NCT01616680
- Sponsor
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.